MEDICAL PROPERTIES TRUST INC (MPW)

US58463J3041 - REIT

4.02  +0.07 (+1.77%)

After market: 4.04 +0.02 (+0.5%)

Fundamental Rating

2

Taking everything into account, MPW scores 2 out of 10 in our fundamental rating. MPW was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of MPW have multiple concerns. MPW does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

MPW had negative earnings in the past year.
In the past year MPW had a positive cash flow from operations.
MPW had positive earnings in 4 of the past 5 years.
MPW had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

MPW's Return On Assets of -17.48% is on the low side compared to the rest of the industry. MPW is outperformed by 96.83% of its industry peers.
MPW's Return On Equity of -48.96% is on the low side compared to the rest of the industry. MPW is outperformed by 93.65% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.14%, MPW is doing worse than 90.48% of the companies in the same industry.
MPW had an Average Return On Invested Capital over the past 3 years of 2.90%. This is in line with the industry average of 3.11%.
Industry RankSector Rank
ROA -17.48%
ROE -48.96%
ROIC 0.14%
ROA(3y)1.57%
ROA(5y)1.97%
ROE(3y)3.64%
ROE(5y)4.41%
ROIC(3y)2.9%
ROIC(5y)3.2%

1.3 Margins

MPW has a worse Operating Margin (3.91%) than 89.68% of its industry peers.
MPW's Operating Margin has declined in the last couple of years.
MPW has a better Gross Margin (96.76%) than 97.62% of its industry peers.
MPW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.91%
PM (TTM) N/A
GM 96.76%
OM growth 3Y-48%
OM growth 5Y-33.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-0.6%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MPW is destroying value.
MPW has more shares outstanding than it did 1 year ago.
MPW has more shares outstanding than it did 5 years ago.
MPW has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.07, we must say that MPW is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.07, MPW is doing worse than 80.95% of the companies in the same industry.
The Debt to FCF ratio of MPW is 90.96, which is on the high side as it means it would take MPW, 90.96 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 90.96, MPW perfoms like the industry average, outperforming 50.79% of the companies in the same industry.
A Debt/Equity ratio of 1.69 is on the high side and indicates that MPW has dependencies on debt financing.
MPW's Debt to Equity ratio of 1.69 is on the low side compared to the rest of the industry. MPW is outperformed by 68.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 90.96
Altman-Z -0.07
ROIC/WACC0.03
WACC5.17%

2.3 Liquidity

A Current Ratio of 1.73 indicates that MPW should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.73, MPW is in the better half of the industry, outperforming 70.63% of the companies in the same industry.
MPW has a Quick Ratio of 1.73. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.73, MPW is in the better half of the industry, outperforming 73.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.73

1

3. Growth

3.1 Past

The earnings per share for MPW have decreased strongly by -2428.57% in the last year.
MPW shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.94% yearly.
MPW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -53.35%.
The Revenue has been growing slightly by 2.13% on average over the past years.
EPS 1Y (TTM)-2428.57%
EPS 3Y-24.4%
EPS 5Y-18.94%
EPS Q2Q%-805.26%
Revenue 1Y (TTM)-53.35%
Revenue growth 3Y-11.3%
Revenue growth 5Y2.13%
Sales Q2Q%-26.34%

3.2 Future

MPW is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.74% yearly.
Based on estimates for the next years, MPW will show a decrease in Revenue. The Revenue will decrease by -4.49% on average per year.
EPS Next Y-862.79%
EPS Next 2Y-15.4%
EPS Next 3Y-16.74%
EPS Next 5YN/A
Revenue Next Year-22.77%
Revenue Next 2Y-14.95%
Revenue Next 3Y-8.47%
Revenue Next 5Y-4.49%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

MPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MPW is valuated correctly with a Price/Forward Earnings ratio of 16.05.
MPW's Price/Forward Earnings ratio is rather cheap when compared to the industry. MPW is cheaper than 96.03% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MPW to the average of the S&P500 Index (23.45), we can say MPW is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 16.05

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MPW is valued more expensive than 90.48% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MPW is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.82
EV/EBITDA 22.96

4.3 Compensation for Growth

MPW's earnings are expected to decrease with -16.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.4%
EPS Next 3Y-16.74%

5

5. Dividend

5.1 Amount

MPW has a Yearly Dividend Yield of 8.51%, which is a nice return.
The stock price of MPW dropped by -29.72% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MPW's Dividend Yield is rather good when compared to the industry average which is at 15.86. MPW pays more dividend than 85.71% of the companies in the same industry.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 8.51%

5.2 History

The dividend of MPW has a limited annual growth rate of 0.77%.
MPW has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.77%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-13.67%
EPS Next 2Y-15.4%
EPS Next 3Y-16.74%

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (1/2/2025, 8:04:00 PM)

After market: 4.04 +0.02 (+0.5%)

4.02

+0.07 (+1.77%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst Owners65.56%
Inst Owner Change-0.34%
Ins Owners7.35%
Ins Owner Change-1.82%
Market Cap2.41B
Analysts51.58
Price Target4.91 (22.14%)
Short Float %45.37%
Short Ratio20.16
Dividend
Industry RankSector Rank
Dividend Yield 8.51%
Dividend Growth(5Y)0.77%
DP-13.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1751.67%
Min EPS beat(2)-2512.24%
Max EPS beat(2)-991.09%
EPS beat(4)1
Avg EPS beat(4)-788.37%
Min EPS beat(4)-2512.24%
Max EPS beat(4)536.49%
EPS beat(8)1
Avg EPS beat(8)-443.78%
EPS beat(12)5
Avg EPS beat(12)-272.67%
EPS beat(16)7
Avg EPS beat(16)-207.72%
Revenue beat(2)1
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-9.56%
Max Revenue beat(2)5.9%
Revenue beat(4)2
Avg Revenue beat(4)0.19%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)7.24%
Revenue beat(8)3
Avg Revenue beat(8)-1.63%
Revenue beat(12)4
Avg Revenue beat(12)-2.08%
Revenue beat(16)6
Avg Revenue beat(16)-1.17%
PT rev (1m)-2.53%
PT rev (3m)-6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-53.64%
EPS NY rev (1m)-53.68%
EPS NY rev (3m)-159.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.36%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-2.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.05
P/S 3.76
P/FCF 23.82
P/OCF 7.93
P/B 0.44
P/tB 0.44
EV/EBITDA 22.96
EPS(TTM)-1.77
EYN/A
EPS(NY)0.25
Fwd EY6.23%
FCF(TTM)0.17
FCFY4.2%
OCF(TTM)0.51
OCFY12.6%
SpS1.07
BVpS9.06
TBVpS9.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.48%
ROE -48.96%
ROCE 0.17%
ROIC 0.14%
ROICexc 0.14%
ROICexgc 0.14%
OM 3.91%
PM (TTM) N/A
GM 96.76%
FCFM 15.8%
ROA(3y)1.57%
ROA(5y)1.97%
ROE(3y)3.64%
ROE(5y)4.41%
ROIC(3y)2.9%
ROIC(5y)3.2%
ROICexc(3y)2.96%
ROICexc(5y)3.34%
ROICexgc(3y)3.03%
ROICexgc(5y)3.41%
ROCE(3y)3.68%
ROCE(5y)4.05%
ROICexcg growth 3Y-55.37%
ROICexcg growth 5Y-43.01%
ROICexc growth 3Y-55.51%
ROICexc growth 5Y-42.22%
OM growth 3Y-48%
OM growth 5Y-33.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-0.6%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 90.96
Debt/EBITDA 18.71
Cap/Depr 43.4%
Cap/Sales 31.63%
Interest Coverage 0.06
Cash Conversion 61.75%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.73
Altman-Z -0.07
F-Score3
WACC5.17%
ROIC/WACC0.03
Cap/Depr(3y)699.06%
Cap/Depr(5y)1326.09%
Cap/Sales(3y)161.44%
Cap/Sales(5y)274.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2428.57%
EPS 3Y-24.4%
EPS 5Y-18.94%
EPS Q2Q%-805.26%
EPS Next Y-862.79%
EPS Next 2Y-15.4%
EPS Next 3Y-16.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-53.35%
Revenue growth 3Y-11.3%
Revenue growth 5Y2.13%
Sales Q2Q%-26.34%
Revenue Next Year-22.77%
Revenue Next 2Y-14.95%
Revenue Next 3Y-8.47%
Revenue Next 5Y-4.49%
EBIT growth 1Y-95.54%
EBIT growth 3Y-53.88%
EBIT growth 5Y-32.07%
EBIT Next Year73.97%
EBIT Next 3Y19.34%
EBIT Next 5Y13.88%
FCF growth 1Y107.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.6%
OCF growth 3Y-6.44%
OCF growth 5Y2.41%